The small GTPase-encoding gene RhoB is strongly induced as part of the immediate early response of serum-stimulated fibroblasts. In this report, we have characterized the mechanism for growth factor responsiveness of RhoB in Rat-2 fibroblasts. By Northern blotting and ribonuclease protection, we observed low or barely detectable levels of RhoB mRNA in quiescent cells, but expression was transiently induced in response to serum stimulation, such that the mRNA peaked within 30 min and then declined over the next hour. Analysis of the rat promoter revealed cis-elements conserved with the mouse and human genes, including a pair of CEBP sites near the transcriptional start site. However, in contrast to the analysis of RNA, RhoB promoter fusions were constitutively expressed in quiescent cells in transient transfections, and were unaffected by serum. Similarly, stable RhoB promoter integrants were highly expressed in quiescent cells, and growth factor caused a slight decrease in activity. This indicates that growth factor-inducible RhoB expression cannot be mediated by transcriptional activation. We then examined decay of the RhoB mRNA and found that serum caused significant stabilization. Additionally, fusion of the 3 0 RhoB untranslated region (UTR) to a constitutively expressed reporter gene caused serum and growth factor as well as DNA damageinducible expression. These observations are consistent with the view that RhoB mRNA is produced constitutively but its abundance is controlled in response to growth factors, and other signals including DNA damage, by stabilization through elements within the 3 0 UTR.
Introduction
Stimulation of quiescent cells with growth factors causes rapid induction of a variety of genes whose products contribute to cell cycle re-entry (Winkles, 1998) . Growth factor-responsive immediate early genes in fibroblasts include those encoding transcription factors of the Fos/ Jun/Fra, Fgr, and NGFI families, various growth factors and cytokines, cytoskeletal components, and the small Ras-related GTPase RhoB (Jahner and Hunter, 1991) . The Rho subgroup of small GTPases, including RhoA, B, and C are involved in regulation of actin stress fibers (Prendergast, 2001) . Despite their similar structure, the Rho proteins have distinct biological functions, which may relate to different subcellular distribution (Adamson et al., 1992a, b) . RhoB is unique among this subclass of small GTPases because its expression is induced in response to genotoxic agents as well as mitogens, unlike RhoA and C (Fritz et al., 1995 (Fritz et al., , 1999 Jahner and Hunter, 1991) . Indeed, RhoB is required for DNA-damageinduced apoptosis of mouse embryonic fibroblasts (Liu et al., 2001) . Additionally, RhoB protein has been shown to be a target for the antineoplastic effects of farnesyltransferase inhibitors (Lebowitz and Prendergast, 1998; Prendergast, 2000) . Consequently, RhoB may be involved in responses to many antineoplast agents and a thorough understanding of its regulation will have important consequences for cancer therapies.
RhoB was identified as an immediate early gene in rat fibroblasts stimulated with growth factors and by the oncogenic v-fps protein tyrosine kinase (Jahner and Hunter, 1991) . Unlike other growth factor-responsive immediate early genes, RhoB expression is not induced by phorbol esters (Jahner and Hunter, 1991) , indicating that induction must occur by a different signaling mechanism than genes such as c-fos and c-jun (Karin et al., 1997) . RhoB expression was also shown to be induced in response to DNA damage by u.v. light and alkylating agents (Fritz et al., 1995) . The mouse RhoB promoter was shown to be responsive to genotoxic agents in transfection experiments as a reporter gene fusion Kaina, 1997, 2001) . Consistent with the observation that RhoB expression is not induced by phorbol esters, the mouse promoter was reported to be devoid of binding sites for AP-1, Jun, or Elk (Fritz and Kaina, 1997) . A CCAAT element was shown to be necessary for response to genotoxic agents and was found to bind a protein complex containing ATF-2 and NF-YA (Fritz and Kaina, 2001) . RhoB expression appears to be autoregulated by the Rho GTPases, as overexpression of Rac or Rho guanine dissociation inhibitor (GDI) causes activation, whereas overproduction of RhoB or RhoA val19 inhibits expression from the RhoB promtoter (Fritz and Kaina, 1997) . This autoregulatory effect appears to involve elements within a 170 nucleotide core promoter fragment which operates independently of the JNK, ERK, and p38 MAP kinase pathways, but the specific factors involved have not been identified (Fritz and Kaina, 1997) .
Also, unlike RhoA and C, RhoB is an unstable protein that accumulates transiently in response to growth factors and DNA-damaging agents (Fritz and Kaina, 1997; Engel et al., 1998) , and appears periodically during S phase of the cell cycle (Zalcman et al., 1995) . RhoB is post-translationally modified at the C terminus by different prenyltransferases to produce farnesyl or geranylgeranyl isoprenylated isoforms, which may have different subcellular localization (Adamson et al., 1992a; Lebowitz et al., 1995) . Farnesyltransferase inhibitors (FTIs) cause accumulation of the geranylgeranylated isoform (RhoB-GG), which mediates the antineoplastic effects of these drugs . RhoB is also necessary for DNA-damage-induced apoptosis caused by doxyrubicin and gamma irradiation (Liu et al., 2001) . Additionally, transformed RhoB null cells are resistant to the apoptotic effect of the microtubule inhibitor taxol (Liu et al., 2001) . From these observations, it has been proposed that RhoB may be necessary for intracellular trafficking of components of a DNAdamage-activated death effector pathway (Liu et al., 2001; Prendergast, 2001 ). This view might account for the fact that RhoB function seems to selectively impact the growth response of transformed cells (Prendergast, 2001 ), a feature which makes it a central molecule in cancer chemotherapy.
Despite its initial identification as a growth factor and tyrosine kinase-responsive immediate early gene (Jahner and Hunter, 1991) , a mechanism has yet to be characterized for cell growth signal-responsive induction of RhoB expression. In this work, we have characterized the rat RhoB promoter and its expression in fibroblasts. We found that the promoter is constitutively active in quiescent cells and is not induced upon stimulation with serum or epidermal growth factor, in both transient transfection experiments and stably transfected cell lines. RhoB mRNA was found to be stabilized in serum-stimulated cells, and furthermore, a 3 0 RhoB cDNA fragment could confer serum-and EGF-inducible expression to an otherwise constitutively expressed reporter gene. The 3 0 RhoB untranslated region (UTR) also conferred responsiveness to the DNA-damaging agent cisplatin, indicating that a variety of cellular signals regulate RhoB expression through transient stabilization of its mRNA. These findings are significant because they indicate that RhoB expression is regulated at multiple levels including transcriptional activation as well as RNA and protein stability.
Results

Growth-factor-responsive expression of RhoB in rat fibroblasts
RhoB was identified as a protein-tyrosine kinase immediate early responsive gene in rodent fibroblasts (Jahner and Hunter, 1991) . Consistent with these observations, we observe induction in Rat-2 fibroblasts expressing a temperature-sensitive v-fps tyrosine kinase mutant (DeClue et al., 1987) within 10 min upon a shift from the nonpermissive to the permissive temperature, as measured by Northern blotting (Figure 1a , lanes 1 and 2). Additionally, treatment of quiescent fibroblasts with epidermal growth factor (EGF) causes induction within 30 min (Figure 1a, lanes 3 and 4) . Like other immediate early inducible transcripts, RhoB RNA becomes degraded by 60 min postinduction (lanes 5 and 6, and not shown). A similar result is observed using ribonuclease protection analysis with two different 5 0 end probes on RNA from quiescent Rat-2 fibroblasts stimulated with serum ( Figure 1b) . In these experiments, we observe several hundred-fold induction within 30 min (compare lanes 1 and 2), and then a decay of the transcripts over the following hour (lanes 3 and 4). These observations are consistent with previous results (Jahner and Hunter, 1991) , and demonstrate that RhoB expression is transiently induced in response to growth factor stimulation.
Structure of the Rat RhoB promoter
The mouse RhoB promoter has been examined in some detail in NIH3T3 fibroblasts Kaina, 1997, 2001 ), but a mechanism for growth factor responsiveness has not been identified. With the objective of identifying conserved cis-elements that might be necessary for regulation, we cloned and sequenced rat RhoB genomic DNA for comparison to the mouse sequence. We have also annotated the human RhoB gene (ArhB) from genomic and EST sequences present in GenBank, and prepared an alignment of the three promoter antisense RhoB probes flanking the transcriptional start site prepared from pGrb440 (top), and pGrb213 (center), or with an actin probe prepared from pTRI-Act (bottom). RhoB mRNA protects 390 and 100 nucleotides of the RhoB probes, respectively sequences ( Figure 2) . As is the case for the mouse gene, both the rat and human RhoB genes are intronless (not shown). Southern blotting analysis was used to confirm that our Rat genomic DNA clones did not represent a pseudogene (not shown). We used a combination of ribonuclease protection and primer extension (see Figure 1b , and not shown) to map the transcriptional start site on the Rat gene to one major (designated þ 1 in Figure 2 ) and two minor sites within a purine-rich segment. The initiation site is conserved between the rat and mouse promoter sequences (Fritz and Kaina, 1997) , and occurs 34 nucleotides downstream of a putative TATA element (boxed, Figure 2 ). The rat, mouse, and human RhoB sequences are highly conserved within the core promoter region (À95 to þ 43), with 92% identity between the rodent species and 95% identity between rat and human. Significant identity (74%) between the human and rodent promoters extends to À440, upstream of which exists a long poly-GT segment in the human sequence (not shown). Further upstream, the rodent promoters are highly conserved to at least À1 kb ( Figure 2 , and not shown), except for several long uninterrupted A stretches between À452 and À475 that are not present in the mouse promoter (Figure 2) .
Consistent with previous observations, we also observed induction of RhoB in serum-stimulated mouse NIH3T3 cells (not shown). We reasoned that since RhoB is strongly induced by growth factors in both mouse and rat fibroblasts, any cis-acting promoter elements required for this effect should be conserved between the two species. To identify putative conserved elements, we analysed the mouse and rat promoter sequences in silico using the TRANSFAC database with MatInspector (Wingender et al., 2000) . Within the 1 kb DNA fragment representing the core promoter and immediate 5 0 region (Figure 2 ), this analysis identified in excess of 150 (nonredundant) matches with matrix similarities greater than 0.85 on each sequence (not shown). However, among these, we observed only 14 predicted elements that were conserved on the promoters from both rodent species (boxed and labeled, Figure 2 ). Matrix similarities of the conserved elements varied from 0.850 to 0.963. Interestingly, the two binding sites for CEBP at À44 and À92 were conserved between the two rodent and the human sequences. These sites have previously been shown to bind ATF-2/NF-YA in vitro, and to be responsive to the SAPK stress-responsive signaling pathway in NIH3T3 cells (Fritz and Kaina, 2001 ). We did not observe a serum response element in any of the promoters, and apart from a predicted AP1 site at À136, the sequences do not contain elements for known factors that might contribute to growth factor-responsive transcription.
The rat RhoB promoter is constitutive in serum-starved fibroblasts
To determine whether transcription from the rat RhoB promoter is stimulated by growth factors, we constructed fusions of 5 0 genomic DNA fragments with a chloramphenicol acetyl transferase (CAT) reporter gene. The constructs were transiently transfected into Rat-2 fibroblasts, and CAT activity was measured in quiescent cells and cells stimulated with 10% FBS for 60 min ( Figure 3 ). In these experiments, we found that a RhoB genomic DNA fragment comprising nucleotides approximately À3200 to þ 381 of the transcriptional start site directed expression of CAT activity at a level approximately equivalent to a control SV40 early promoter construct in both quiescent and stimulated cells ( Figure 3 ). However, in parallel experiments, we observed serum-responsive CAT expression in cells transfected with a c-Fos-CAT reporter construct (Stumpo et al., 1988) . This indicates that under the conditions of a transient transfection assay, the Rat RhoB promoter is constitutively active, even in quiescent cells, and under conditions where the c-fos promoter can be stimulated by serum. We also examined a series of promoter deletions, but in no case did we observe significant induction in response to serum (Figures 3 and 4 , and not shown). A construct containing nucleotides À59 to Mitogen-responsive RhoB expression T Malcolm et al þ 153, fused upstream of CAT, was nearly as active as larger promoter fusions (Figure 3 ), indicating that most constitutive promoter activity in transient transfections is contributed by elements proximal to the putative TATA box; this fragment contains the most proximal of the two conserved CEBP elements. Sequences from À59 to þ 153 are also necessary for promoter activity, as a construct containing residues from approximately À3200 to À59 was completely inactive as a promoter (Figure 3) . To examine the possibility that transient transfections might unmask activity of an element that is normally inactive in quiescent cells on the larger genomic fragments, we also assayed a series of 5 0 truncated promoters in both mouse NIH3T3 cells and Rat-2 fibroblasts (Figure 4) . We found that each of the promoter deletions was constitutively expressed in quiescent cells, and was unaffected by serum stimulation (Figure 4 , and not shown). Deletion of sequences 5 0 of residue À801 caused a significant increase in expression in quiescent cells (Figure 4 , compare À801 to À964), suggesting that the conserved NF1 element might be inhibitory. With the exception of the À304 and À410 deletions, further 5 0 deletions to À272 had roughly comparable activity (Figure 4) . Curiously, the À410 deletion consistently had greater activity in Rat-2 fibroblasts than in NIH3T3 cells. We have not examined the significance of this observation further. Deletions of DNA containing the SP1 site at À228 and AP1/AP2 sites at À135/À153 caused decreased expression. These results indicate that factors upstream of the core promoter (À200 to À300) likely positively influence transcription, while elements further upstream (À800 to À900) may confer negative regulation. Importantly, consistent with the experiments of Figure 3 , we did not observe stimulation by serum in transfections with any of the RhoB promoter deletions in either Rat-2 or NIH3T3 cells, nor in similar experiments performed with HeLa cells (not shown). These observations indicate that the RhoB promoter binds factors which are constitutively active in quiescent fibroblasts, and that transcription cannot be further induced by serum stimulation, at least in transient transfection experiments. 
RhoB (-3200 --59) Figure 3 The Rat RhoB promoter is not responsive to serum. Plasmids pEE100 (À3200 to þ 381), pEE101 (À3200 to þ 153), pEE102 (À59 to þ 381), pEE103 (À59 to þ 153), and pEE104 (À59 to þ 153) containing the indicated RhoB genomic sequences fused to CAT were transfected into Rat-2 fibroblasts. Relative CAT Activity Figure 4 Constitutive activity of the RhoB promoter in quiescent Rat-2 and NIH3T3 fibroblasts. RhoB promoter-CAT fusion plasmids pEE110 (À964), pEE111 (À801), pEE112 (À589), pEE113 (À410), pEE114 (À304), pEE115 (À272), pEE116 (À207), pEE117 (À123), and pEE103 (À59) bearing the indicated 5 0 end deletion point were transfected into Rat-2 fibroblasts (solid bars) or mouse NIH3T3 fibroblasts (open bars). CAT activity (right) was measured from cells that had been rendered quiescent by treatment with 2% calf serum for 48 h. Results are an average of at least four independent experiments. The location of putative conserved cis-elements and the A-rich sequence unique to the Rat promoter (AAA) is indicated (left)
Expression of the endogenous RhoB gene is unaffected in transfected cells
The mouse RhoB promoter is known to be stimulated by DNA damage and other physiological stresses Kaina, 1997, 2001; Fritz et al., 1995) . Owing to these observations, we wondered whether transfected RhoB promoters might be constitutive in quiescent cells because of cellular stress imposed by the transfection protocol. To examine this possibility, we measured expression of the endogenous RhoB gene in transfected cells. We found that RhoB mRNA was undetectable in quiescent cells that had been transfected with the control plasmids pGEM7 (Figure 5, lane 3) or pFos-CAT (lane 5) as measured by ribonuclease protection with a 5 0 end probe (pGrb440, see Figure 2 ). In both cases, RhoB expression was induced in response to serum stimulation (lanes 4 and 6). In a parallel experiment, we found that a transfected RhoB-CAT construct containing sequences À3200 to þ 256 was constitutively expressed in transfected quiescent cells ( Figure 6 , lane 1), and was unaffected by serum stimulation (lane 2). This experiment demonstrates that the endogenous RhoB promoter is not affected by cellular stresses that might be imposed by the transfection procedure, and are consistent with the results shown above indicating that transiently transfected RhoB promoter fragments are constitutive.
Chromatin does not assemble efficiently on transiently transfected plasmid templates (Lee and Archer, 1994) . Consequently, we wondered whether transiently transfected RhoB promoter constructs might be constitutively expressed because chromatin structure may be necessary to repress basal transcription in quiescent cells. To examine this possibility, we constructed stably transfected Rat-2 cell lines with several different RhoB-CAT promoter constructs. Expression of RhoB was monitored by measuring CAT activity in pools of transfected cells ( Figure 6 ) and at least six individual clones derived from each reporter construct (not shown). In these experiments, we did not observe stimulation of CAT expression by serum stimulation. As with the transiently transfected constructs, all of the reporters were constitutively expressed in quiescent cells, and furthermore expression was found to decrease slightly over a period of 90 min following stimulation with EGF ( Figure 6 ). In particular, the stably transfected reporter construct bearing sequences À3200 to þ 153 from the transcriptional start site was expressed at relatively high levels in quiescent cells and expression was reduced by approximately one-third at 90 min postserum stimulation. A truncated reporter containing only the core promoter elements (À59 to þ 153) was expressed at significantly lower levels than either of the two larger reporter constructs (À3200 and À897) in the stably transfected lines. This is in contrast to transient transfections where the core promoter had comparable activity to the same larger promoter constructs (see Figures 3 and 4) . These observations indicate that sequences upstream of the core promoter (À897 to À59) are necessary for RhoB expression within chromosomal DNA, but do not appear to contribute to regulation by growth factors.
RhoB mRNA is stabilized in serum-stimulated cells
Several growth factor-and cytokine-responsive genes have been shown to be regulated through stabilization Figure 5 The endogenous RhoB gene is growth factor responsive in transiently transfected cells. Rat-2 fibroblasts were transiently transfected with pEE100 (RhoB-CAT, lanes 1 and 2), pGEM3Zf(À) (lanes 3 and 4) , or pFos-CAT (lanes 5 and 6) and made quiescent by serum limitation for 48 h. RNA was extracted from quiescent cells (lanes 1, 3, and 5), or cells treated with 20 ng/ ml EGF for 60 min (lanes 2, 4, and 6), and analysed by ribonuclease protection for RhoB (top) or actin (bottom) transcripts using the pGrb440 and pTri-Act probes, respectively Mitogen-responsive RhoB expression T Malcolm et al of their mRNAs (Chen and Shyu, 1995; Wilusz et al., 2001) . Consequently, we examined whether RNA stabilization might serve as a mechanism for induction of RhoB in serum-stimulated cells. For this experiment, we deprived subconfluent Rat-2 fibroblasts of serum for 2 h to allow decay of RhoB transcripts to a level which could be detected by Northern blotting (Figure 7 , time 0, lane 1). RhoB was still inducible in cells treated in this manner, as readdition of serum (20% fetal bovine serum (FBS)) caused some accumulation of transcripts within an hour ( Figure 7 , lanes 2-4). To determine the effect of serum stimulation on RhoB mRNA stability, serumdeprived cells were treated with the transcription inhibitor actinomycin D in the presence (20% FBS, Figure 7 , lanes 8-10) or absence (2% CS, lanes 5-7) of serum. In unstimulated cells, we observe an almost complete decay of RhoB transcripts within 2 h (lane 7). In contrast, addition of serum prevented decay of the RhoB mRNA, such that a significant amount of transcript was observed 2 h postaddition of actinomycin D, indicating that serum causes its stabilization.
The RhoB 3 0 UTR confers growth factor and DNAdamage inducibility Both the rodent and human RhoB cDNAs contain AUrich elements (AREs) within the 3 0 UTR (see below). AREs are known to be potent destabilizing sequences (Chen and Shyu, 1995) , and several ARE-containing mRNAs have been shown to be stabilized in growth factor-stimulated cells (Winzen et al., 1999; Balmer et al., 2001; Wilusz et al., 2001) . To determine whether a similar mechanism might operate to regulate RhoB, we created a reporter gene in which the 3 0 end of the rat RhoB cDNA was fused to a heterologous luciferase reporter gene expressed from a constitutive promoter. We found that fusion of a 1.37 kb 3 0 end RhoB cDNA fragment to luciferase expressed from the SV40 early promoter caused significant serum-responsive expression (Figure 8a, RhoB) , and also responsiveness to treatment of quiescent cells with EGF (Figure 8b , RhoB). In contrast, a comparable reporter fusion with a 1 kb actin cDNA 3 0 end fragment was completely unresponsive to serum (Figure 8a , Act). This indicates that growth factor-responsive expression of RhoB can be conferred by the 3 0 UTR region. Several transcripts containing AU-rich elements within the 3 0 UTR are known to be stabilized in response to u.v. irradiation and other DNA-damaging agents. Consistent with these reports, treatment of quiescent cells with cisplatin also caused significant induction of the luciferase-RhoB 3 0 UTR fusion reporter (Figure 8c ). In combination with the results shown above, these observations suggest that a variety of cellular signals control RhoB mRNA abundance by mechanisms involving the 3 0 UTR. The Cyr61 mRNA contains five potential AREs within the 3 0 UTR, and is also stabilized in serumstimulated fibroblasts (Leng et al., 2002) . Fusion of the 3 0 Cyr61 UTR to a constitutively expressed luciferase reporter also caused serum-responsive luciferase expression (Figure 8a, Cyr61) , similar to the luciferase-RhoB 3 0 UTR fusion. However, in contrast, we did not observe induction of the luciferase-Cyr61 3 0 UTR reporter in cells treated with cisplatin (Figure 8c , Cyr61). Consistent with this observation, we do not observe significant induction of Cyr61 transcripts by Northern blotting in cells treated with DNA-damaging agents (not shown). Therefore, even though both RhoB and Cyr61 contain AREs within their 3 0 UTR, they appear to be subject to distinct but partially overlapping regulatory mechanisms. 
Discussion
It is becoming increasingly apparent that a significant number of growth factor-and cytokine-responsive genes are regulated at least in part through control of transcript stability (Wilusz et al., 2001) . Many of the initial transcripts shown to be stabilized by growth factor or cytokine stimulation themselves encode cytokines and chemokines, including IL-6, IL-8, GM-CSF (Winzen et al., 1999) , IL-2 (Chen et al., 1998) , IL-3 (Ming et al., 1998) , IFN-g (Lindstein et al., 1989) , RANTES (Li and Bever, 2001) , and VEGF (White et al., 1997) . This mode of regulation is not specific to cytokines and growth factors, as the EGF receptor (Balmer et al., 2001) , c-fos (Lindstein et al., 1989) , and cyclooxygenase-2 (Ridley et al., 1998; Dean et al., 1999) mRNAs have also been found to be regulated by RNA stability. In this work, we demonstrate that RhoB mRNA is stabilized in serum-stimulated fibroblasts, and that the 3 0 end of its transcript can confer growth factor inducibility when fused to a heterologous constitutively expressed reporter gene.
We initially characterized the RhoB promoter because of our interest in transcriptional regulatory proteins which are regulated by tyrosine kinase-responsive signaling. Most attention on the mechanisms of growth factor-responsive immediate early genes has focused on transcriptional activators such as AP1 (fos/jun), Etsfamily members, the signal transducers and activators of transcription (STATs), and serum response factor (SRF), whose activities have been defined as targets for downstream protein tyrosine kinase signaling (Karin and Hunter, 1995; Karin et al., 1997) . To our surprise, we could find no evidence that RhoB transcription is induced by growth factor stimulation. In both transient transfections and with stable cell lines, we found that a 3.2 kb 5 0 flanking RhoB DNA fragment was constitutively active in quiescent fibroblasts. In no case did we observe induction in response to growth factors, either in stable lines or transient assays, nor with any of the promoter deletion constructs. Instead, in cells stably transfected with three different promoter deletion constructs, we observed a slight decrease in activity following stimulation of quiescent cells with growth factor, over the same period in which we observe transient accumulation of endogenous RhoB mRNA. This indicates that the 5 0 promoter RhoB promoter elements cannot contribute to growth factor-responsive expression. Our results cannot exclude the possibility that cis-acting elements upstream of À3200, or downstream of the RhoB gene, might be necessary for growth factor-responsive expression. However, such elements would have to completely repress activation of the otherwise constitutive RhoB promoter in quiescent cells.
A search of the mouse and rat promoters with the TRANSFAC database identifies more than 100 potential binding sites for various factors on each. Surprisingly, despite the relatively high identity between the sequences, only 14 of these predicted elements were conserved between these rodent species (indicated in Figure 2 ). The seven most proximal of the predicted elements are also conserved in the human promoter (Figure 2) . Importantly, among these were two CEBP elements near the promoter core that have been shown to be necessary for stress-responsive RhoB expression Kaina, 1997, 2001 ). An AP1 site is conserved near À140 of the rat sequence, but this element does not appear to contribute to growth factor responsiveness, as the À207 and larger RhoB deletion constructs were constitutive in quiescent cells (Figure 4 ) and were unresponsive to growth factor stimulation (not shown). In transient transfections, most of the promoter activity appears to be contained within the À207 to þ 153 fragment, although sequences further upstream are necessary for expression from templates in stable cell lines.
Our results suggest that RhoB mRNA is synthesized constitutively, but is rapidly turned over in quiescent cells. Stimulation with serum causes stabilization of the mRNA allowing its accumulation. Several sequence elements have been identified that can influence transcript stability, the most well characterized are the ARE, which are typically found in the 3 0 UTR and promote destabilization (Chen and Shyu, 1995) . A number of ARE-containing transcripts have been shown to be stabilized in response to signal transduction (Wilusz et al., 2001) . The IL-2 mRNA is stabilized in activated T cells by a mechanism involving JNK and a JNKresponsive element in the 5 0 UTR (Chen et al., 1998) . Cytokine and growth factor-induced stabilization of the ARE-containing GM-CSF, c-fos, IL-2, and IL-8 mRNAs involves the p38 MAPK pathway (Winzen et al., 1999) . Growth factor responsiveness of the EGFreceptor mRNA has also been shown to be mediated by AREs (Balmer et al., 2001) . The RhoB 3 0 end has several sequences resembling AREs, including one similar to the group IID consensus ARE (AAUUUAUUUAA) at þ 1815, and a second group I-related ARE (AUUUA) at þ 2125 (Wilusz et al., 2001) . The rodent and human 3 0 UTRs have approximately 70% sequence identity, and accordingly this region of the human transcript has two group IID-, and one group 1-related sequence. We have previously demonstrated that the immediate early gene Cyr61, encoding an ECM-associated integrin ligand (Lau and Lam, 1999) , is also regulated at least in part by RNA stabilization (Leng et al., 2002) . The rat Cyr61 transcript contains four putative group I class ARE elements within the 3 0 UTR (Leng et al., 2002) . The RhoB, but not the Cyr61, 3 0 UTR was also capable of conferring DNA-damage-inducible expression of a heterologous reporter gene. This result is consistent with previous observations that u.v. irradiation causes stabilization of a variety of short-lived ARE-containing transcripts, including c-fos, c-jun, and c-myc by a mechanism thought to involve activation of JNK (Blattner et al., 2000) .
RhoB is a critical protein for cellular responses to DNA damage and the effect of antineoplastic agents, and its expression and activity appears to be stringently regulated by a combination of mechanisms including transcriptional regulation and control of RNA stability. Additionally, the RhoB protein is itself turned over rapidly, and its function may be regulated by differential isoprenylation (Prendergast, 2001) . Our results suggest that RNA stability plays an important role in regulating RhoB expression in response to growth and DNAdamage-induced signaling mechanisms. The RhoB protein is also known to appear transiently during S phase (Fritz et al., 1999) . Stimulation of quiescent cells with growth factors causes re-entry of G o cells into S phase of the cell cycle, and therefore it is possible that cyclic appearance of RhoB might also involve RNA stabilization. Given the apparent significance of RhoB for cancer chemotherapy, it will be important to investigate the mechanisms governing degradation and signal-responsive stabilization of its transcript.
Materials and methods
Cell culture and DNA transfections
Rat-2 and NIH3T3 fibroblasts were grown in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FBS in humidified 5% CO 2 incubators. CNA7 cells are Rat-2 fibroblasts expressing a temperature-sensitive mutation of the v-fps tyrosine kinase oncogene (DeClue et al., 1987) . Cells were rendered quiescent by incubation in DMEM containing 2% calf serum for 48 h. Transfections were performed using calcium phosphate co-precipitation, DEAE dextran or lipofectamine. Stably transfected RhoB promoter-CAT reporter cell lines were produced by cotransfection of the promoter construct plasmids with pSV2-neo at a 10 : 1 ratio. The cells were subcultured 48 h post-transfection and seeded at 1/3 dilution into DMEM supplemented with 10% FBS containing 400 mg/ml G418. CAT assays were performed on whole-cell extracts prepared by freeze thaw, as described previously (Bell and Sadowski, 1996) . Luciferase assays were performed on cells transfected in six-well plates with 1.0 mg of the indicated constructs using Lipofectamine PLUS reagent (Invitrogen) according to manufacturer specifications. Transfected cells were washed with phosphate-buffered saline and activity was determined using the Promega Luciferase Assay system (cat. # E4030). Transfected cells were treated with 20 ng/ml EGF (Calbiochem), or 0.1 mg/ml cisplatin (Sigma) for 1 h prior to assaying luciferase activity.
RNA analysis
RNA was extracted using Ultraspec RNA reagent (BIOTECX Laboratories) or with the RNeasy Midi Kit (Qiagen) as per the manufacturer's instructions. Northern blots contained 20 mg total RNA per lane, resolved on 1% formaldehyde gels, and transferred to Hybond NX nylon membrane (AP Biotech Inc.). RhoB and GAPDH transcripts were detected with randomly primed 32 P-labeled cDNA probe. Antisense RNA probes for ribonuclease protection were produced from the RhoB template plasmids pGrb440 and pGrb213 (see below) linearized with HindIII and transcribed in the presence of [a- 32 P]CTP with SP6 RNA polymerase. The actin control probe was generated from p-TRI-actin (Ambion). Ribonuclease protection assays were performed using the Ambion RPAII kit, as per the manufacturer's instructions. Hybridization reactions contained 1 mg total RNA probe and 2 Â 10 5 c.p.m. gel-purified antisense riboprobe, and the products were resolved on 6% denaturing polyacrylamide gels. The plasmids pSV2-neo, pSV2-CAT, and pFos-CAT (À356 to þ 109) have been described previously (Gorman et al., 1982; Riera et al., 1984; Stumpo et al., 1988) .
Recombinant DNA and sequencing
A RhoB genomic DNA clone was isolated from a rat l Dash library (Clontech) by hybridization with labeled cDNA probes. An 11.5 kB SalI genomic fragment spanning sequences approximately À3200 to þ 8300 relative to the transcriptional start site was subcloned into pGEM3Zf( þ ) to produce pGrb11.5. DNA spanning the upstream SalI site at À3200 to the SacI site immediately upstream of the translational start ( þ 381) was inserted blunt into pOCn, which contains a multiple cloning sequence upstream of the CAT gene with an SV40 polyA fragment, to produce pEE100. Plasmids pEE101 (RhoB À3200 to þ 153), pEE102 (RhoB À59 to þ 381), pEE103 (RhoB À59 to þ 153), and pEE103 (RhoB À3200 to 59) are subcloning derivatives of pEE100. 5 0 promoter deletions were generated by Bal31 digestion from the SphI site of pEE100 to produce pEE110 (RhoB 964 to þ 153), pEE111 (RhoB À801 to þ 153), pEE112 (RhoB À589 to þ 153), pEE113 (RhoB À410 to þ 153), pEE114 (RhoB À304 to þ 153), pEE115 (RhoB À272 to þ 153), pEE116 (RhoB À207 to þ 153), and pEE117 (RhoB À123 to þ 153). DNA sequencing was performed using big dye terminator reactions on an ABI310 capillary instrument, with a minimum of two passes on each strand. Plasmids pGrb440 and pGrb213 for generation of ribonuclease protection probes contain a SacI, and SacI/HindIII fragment, respectively, flanking the transcriptional start site cloned into pGEM7Zf( þ ). RhoB (1.37 kb), Cyr61 (1 kb), and actin (1 kb) 3 0 end fragments were cloned into the SV40 early promoter-luciferase expression plasmid pGL3 (Promega) as XbaI/SalI or Xba/BamHI PCR fragments to generate pDB008, pDB009, and pIS323, respectively. Oligos for PCR were as follows: RhoB, CCGGtctagaTGAAGGCCGCGCCCTGCCTCACGC CCTTGCCAG and GCCGGgtcgacCATCATAAGCTCACCACTTTGTCA-TCT GTCAGT; Cyr61, CCGGtctagaCCCTTGTACAGG-CTGTTCAATGACATTCACA and CCGGgtcgacGGCATA-CACTCAGATATTAGGTAAATATTTC; actin, CCCGGGtctagaGGGCCGTCTTCCCCTCCATCGTGGGGCG, and GCCGGggatccGA AGCATTTGCGGTGGACGATGGA.
